Slippers to Reduce Transfer From Floors to Surfaces

Impact of Wearing Slippers on Transfer of Bacteriophage MS2 From Floors in Patient Rooms to Bedding and Surfaces

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04935892

Enrollment

Registered

2021-06-23

Start date

2020-08-01

Completion date

2021-04-20

Last updated

2021-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transmission, Other/Miscellaneous

Keywords

Floor, Bacteriophage MS2, Contamination, Environment, Healthcare-associated pathogens

Brief summary

The goal of this study is to determine if wearing slippers will reduce transfer of bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients. Subjects are randomized to wear slippers versus standard care and cultures are collected at 24 and 48 hours to assess transfer of bacteriophage MS2 from the floor to high-touch surfaces, personal items, bedding, socks or feet, and hands of patients.

Detailed description

The goal of this study is to determine if wearing slippers will reduce transfer of bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients. Hospitalized patients are enrolled and randomized to wear slippers any time they are out of bed versus standard care. Bacteriophage MS2 is inoculated onto a site on the floor between the patient bed and the bathroom. Cultures are collected at 24 and 48 hours to assess transfer of bacteriophage MS2 from the floor to high-touch surfaces (bed rail, bedside table, telephone, call button), personal items, bedding, socks or feet, and hands of patients.

Interventions

BEHAVIORALSlippers

Patients in the intervention group wear slippers when out of bed

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Masking description

Lab personnel processing cultures blinded to the study group

Intervention model description

Randomized trial

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients of 18 years of age or older * Ambulatory * Able to demonstrate an understanding of study procedures

Exclusion criteria

* Unable or unwilling to fulfill study requirements. * Expected length of stay less than 48 hours * Any patient deemed not suitable for study participation at the discretion of the study investigator

Design outcomes

Primary

Measure	Time frame	Description
Contamination of a composite of high-touch surfaces, personal items, socks/feet, bedding, and hands	48 hours	Cultures for MS2

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026